Qualigen Therapeutics, Inc. — Director's Dealing 2016

Jan 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2016-01-26

Reporting Person: Mochizuki Ellen F. (VP, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-26	Stock Options (2015 Equity Incentive Plan)	$1.39	A	10000	Acquired	2026-01-26	Common Stock (10000)	Direct

Footnotes

F1: 25% of the shares underlying the option will vest on September 21, 2016 and the remaining 75% of the shares will vest in 36 equal monthly investments beginning on the 21st day of each calendar month after September 21, 2016.